MANCHESTER PHARMACEUTICALS

Serial Number 88808499
Registration 6119039
700

Registration Progress

Application Filed
Feb 24, 2020
Under Examination
Approved for Publication
May 19, 2020
Published for Opposition
May 19, 2020
Registered
Aug 4, 2020

Trademark Image

MANCHESTER PHARMACEUTICALS

Basic Information

Serial Number
88808499
Registration Number
6119039
Filing Date
February 24, 2020
Registration Date
August 4, 2020
Published for Opposition
May 19, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 4, 2020
Registration
Registered
Classes
005

Rights Holder

TRAVERE THERAPEUTICS, INC.

03
Address
3611 VALLEY CENTRE DRIVE
SUITE 300
SAN DIEGO, CA 92130

Ownership History

Retrophin, Inc.

Original Applicant
03
San Diego, CA

Retrophin, Inc.

Owner at Publication
03
San Diego, CA

Retrophin, Inc.

Original Registrant
03
San Diego, CA

TRAVERE THERAPEUTICS, INC.

New Owner After Registration #1
03
SAN DIEGO, CA

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

Next Deadline
372 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-08-04)
Due Date
August 04, 2026
Grace Period Ends
February 04, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

14 events
Date Code Type Description Documents
Dec 23, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 4, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 19, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 19, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 29, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 16, 2020 ALIE A ASSIGNED TO LIE Loading...
Apr 6, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 6, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 6, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 6, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 6, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 31, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 27, 2020 NWAP I NEW APPLICATION ENTERED Loading...
Feb 27, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of bile acid synthesis disorders
First Use Anywhere: Apr 6, 2015
First Use in Commerce: Apr 6, 2015

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"